Gentile Kimberly has filed 11 insider transactions across 1 company since November 2023.
Most recent transaction: a grant/award of 175000 shares of Biohaven Ltd. ($BHVN) on February 27, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | A | Stock Options (Right to buy) | 175000 | $0.00 | 175,000.0000 | 105,855,155 | 9999.99% | 0.17% |
| Jan. 5, 2026 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | M | Restricted Share Unit Award | 3750 | $0.00 | 7,500.0000 | 105,855,155 | 33.33% | 0.00% |
| Jan. 5, 2026 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | M | Common Shares | 3750 | $0.00 | 101,513.0000 | 105,855,155 | 3.84% | 0.00% |
| Jan. 5, 2026 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | F | Common Shares | 1956 | $9.93 | 99,557.0000 | 105,855,155 | 1.93% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | M | Restricted Share Unit Award | 3750 | $0.00 | 11,250.0000 | 0 | 25.00% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | M | Common Shares | 3750 | $0.00 | 99,719.0000 | 0 | 3.91% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | F | Common Shares | 1956 | $38.64 | 97,763.0000 | 0 | 1.96% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | A | Stock Options (Right to buy) | 91000 | $0.00 | 91,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2025 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | A | Restricted Share Unit Award | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | A | Stock Options (Right to buy) | 96250 | $0.00 | 96,250.0000 | 0 | 9999.99% | 0.00% |
| Nov. 2, 2023 | Biohaven Ltd. | $BHVN | Gentile Kimberly | SVP, Clinical Operations | A | Stock Options (Right to buy) | 78750 | $0.00 | 78,750.0000 | 0 | 9999.99% | 0.00% |